
@iheartfunctioni
iAccount based inFrance
About this account
- Account based in
- France
- Connected via
- France App Store
Account-level information from X, not a live location or the device used for a specific post.
Advancing trans-disciplinary innovation in #heartfailure drugs and device solutions to improve patient care. #ImprovingHeartFunction
Joined January 2025
- Tweets322
- Following237
- Followers206
- Likes106
🎥 @AlexMebazaa invites you to join the Pre-Course!
Explore practical education in heart failure and cardiogenic shock, and discover what the programme has to offer.
👉 Learn more: pcronline.com/Network/iHF-Im…
🗓️ 21 November, London
#IHF #HeartFailure
⌛Starting in 5 minutes!
Join the iHF faculty live to explore invasive haemodynamic assessment, from right heart catheterisation and key measurements to exercise haemodynamics.
▶️ Join now: pcronline.com/Network/iHF-Im…
💻 LIVE in 6 hours!
How can invasive haemodynamic assessment improve precision in clinical management, and what are the key considerations for right heart catheterisation?
Join today’s free iHF webinar at 5:30pm (UTC+2).
🔗 Register now for free: pcronline.com/Network/iHF-Im…
Missed our live discussion on #HFpEF and coronary microvascular dysfunction? 🫀
The replay is now available.
Explore diagnosis, patient selection and evidence informing tailored treatment strategies through case-based discussion.
🎥 Watch now: pcronline.com/Network/iHF-Im…
🫀 New iHF webinar: Invasive haemodynamic assessment can provide important insights into clinical management.
Explore right heart catheterisation, invasive bedside assessment and exercise haemodynamics during this free live iHF Webinar.
📅 20 October, 5:30pm (UTC+2)
@Marta33717088 @AlexMebazaa
🔗 pcronline.com/Network/iHF-Im…
⌛ Starting in 5 minutes!
Join the iHF faculty LIVE to explore coronary microvascular dysfunction in #HFpEF, from diagnosis and patient selection to tailored treatment strategies.
▶️ Join now: iheartfunction.com/webinars/…
💻 LIVE in 6 hours!
How can coronary microvascular dysfunction be diagnosed in HFpEF, and how can the evidence guide tailored treatment?
Join today’s free iHF Webinar at 5:30pm (UTC+2).
🔗 Register now for free: iheartfunction.com/webinars/…
NEW PRE-COURSE | Cardiogenic shock: "Eyes on the pump" 🫀
Join the iHF & PCR MCS Focus Group on 21 November in London, ahead of #PCRLondonValves.
A focused, interactive Programme on MCS decision-making, device selection, complications, escalation & weaning.
Discover more → pcronline.com/Network/Pre-co…
@PCRonline @AlexMebazaa @EmanueleBarba13 @SabineBleiziff2 @FlavioRibichini
#CardiogenicShock #MCS
Recognising coronary microvascular dysfunction in #HFpEF is only the first step.
Explore diagnosis, patient selection and the evidence informing tailored treatment during this free live iHF Webinar.
📅 29 September, 5:30pm (UTC+2)
🔗 iheartfunction.com/webinars/…
TR in heart failure: when to suspect, when to worry, when to act?
Join our webinar with the PCR Tricuspid Focus Group, featuring @MariannaAdamo1, @masitges, @GMCRosano, Marina Urena & Mirjam Wild.
📅 Thursday 3 September | 5:00 PM UTC+2
Register now: brnw.ch/21x5feQ
@pcr_online #Cardiology #HeartFailure #CardioTwitter
Tricuspid Regurgitation in Heart Failure: when to suspect, when to worry, when to act
🗓️Next live #PCRWebinar: Thursday 3 September 2026, 5:00pm (UTC+2)!
🧑⚕️@MariannaAdamo1, @masitges, @GMCRosano, Marina Urena, Mirjam Wild
✅ Developed by the #PCRTricuspid Focus Group in collaboration with @iheartfunction
🔗Register now: pcronline.com/Webinars/PCR-W…
#MedEd #TricuspidRegurgitation #InterventionalCardiology
🔎 Tricuspid Regurgitation in Heart Failure: when is it time to act?
When should we suspect TR progression? When should we worry about right-heart deterioration? And when should we refer or intervene?
Join the upcoming live webinar in collaboration with @PCRonline Tricuspid Focus Group for an expert discussion.
📅 Thursday 3 September I 5:00 PM (UTC+2)
💻 Online I Free
👉 Register now: pcronline.com/Webinars/PCR-W…
@MariannaAdamo1 @masitges @GMCRosano
#HeartFailure #TricuspidRegurgitation #Cardiology #CardioEducation #CardioTwitter
🔎Do you remember the case of the 39-year-old patient with a late #STEMI complicated by severe biventricular dysfunction and a ventricular septal rupture requiring emergent VA-ECMO and IABP support?
The poll sparked a wide range of opinions - highlighting just how challenging these cases can be.
🫀Now discover how the Heart Team approached this complex mechanical complication, balancing timing, hemodynamic support, and definitive treatment.
📖Read Part 2: iheartfunction.com/cases-res…
#HeartFailure #Cardiology #STEMI #HeartTeam #MedicalEducation #CardioEd
🫀 New Trial Review: the SUBCUT HF II
Presented at #HFA 2026, the SUBCUT-HF II trial explores whether early discharge with an ambulatory subcutaneous furosemide pump could transform heart failure care.
In this Trial Review, @JanBiegus examines the evidence behind this innovative home-based decongestion strategy.
🎥 Watch the full review: iheartfunction.com/news/subc…
#HeartFailure #Cardiology #ClinicalTrials #CardioEd #Cardiology #CardioEducation
🎥Missed our latest iHF webinar? The replay is now available!
Join a multidisciplinary Heart Team discussion on managing patients with HFrEF & chronic coronary syndromes through a real-world case.
🔗 iheartfunction.com/webinars/…
Key topics:
- Patient selection for revascularisation
- PCI vs CABG
- GDMT optimisation after revascularisation
#HeartFailure #Cardiology #HeartTeam #GDMT #CardioEd #CardioTwitter
🫀Can ARNI therapy improve outcomes in patients with #HFpEF and atrial functional mitral regurgitation?
In this new Journal Club, @Jolie_Bruno_ reviews the PRAISE-MR trial published in Circulation and discusses its potential implications for clinical practice.
Read here:
iheartfunction.com/news/angi…
#HeartFailure #Cardiology #JournalClub #ARNI #HFpEF
🫀Post-MI ventricular septal rupture: a critical trans-disciplinary case
A 39-year-old patient with no medical history developed a non-restrictive VSD, severe biventricular dysfunction, and cardiogenic shock following a late #STEMI. Despite #PCI and IABP support, he deteriorated and required VA-ECMO.
👀How would you manage this mechanical complication?
👉 Read the case and vote here:
iheartfunction.com/cases-res…
@EchoSoliman @BarilliMaria
#HeartFailure #CardiogenicShock #ECMO #VentricularSeptalRupture #CardioEd #CardioTwitter
🎥How can #GDMT and #MCS devices optimize the management of patients with advanced heart failure?
Daniel Burkhoff and @AlexMebazaa share key insights from a #EuroPCR 2026 case-based session covering hemodynamic monitoring, short-term MCS, patient stabilization, GDMT optimization, and advanced therapy pathways.
▶️ Watch the full replay: brnw.ch/21x3si4
#AdvancedHeartFailure #HeartFailure #GDMT #Cardiology #CardioEd
⏳Live webinar today: one hour that could change your approach to #HFrEF and #CCS!
📆 19 June 2026 I 5:30pm (UTC+2)
👉Register now: iheartfunction.com/webinars/…
Join a discussion with renowned experts to learn more about patient selection for revascularisation, optimal treatment strategies, and the latest developments in GDMT following intervention.
@MartineGilard @drbennisahmed @ARakisheva
@SabineBleiziff2 @emilianofiorimd @belmontemarta1
#CardioEd #Cardiology #HeartFailure
👀@AlexMebazaa has a message for you...
Join us on Friday for an #iHF webinar and discover the latest advances in optimising care for patients with #HFrEF and #CCS, presented by a trans-disciplinary team of experts.
📆 June 19 I 17:30 (UCT+2)
👉 Register now: iheartfunction.com/webinars/…
@SabineBleiziff2 @drbennisahmed @emilianofiorimd @MartineGilard @ARakisheva @belmontemarta1
#CardioEd #MedicalEducation #HeartFailure
⏳Only 3 days until our next #iHF Webinar!
Which patients with #HFrEF and CAD should undergo revascularisation? What is the best strategy? And how should GDMT be optimised afterwards?
Join our upcoming webinar and discuss these key questions with leading experts!
👉Register now: iheartfunction.com/webinars/…
#CardioEd #Cardiology @MartineGilard @ARakisheva @drbennisahmed @SabineBleiziff2 @emilianofiorimd @belmontemarta1












